Axsome Therapeutics AXSM
NASDAQ AXSM
$179.25 -2.82 (-1.55%)
At close: Oct 2, 2026 · 4:00 PM EDT

Axsome Therapeutics (AXSM) Other Accumulated Expenses (2015 - 2026)

Updated

Axsome Therapeutics' Other Accumulated Expenses came in at $204.63 million for Q2 2026, up 73.2% from $118.17 million a year earlier and up 20.2% from the prior quarter.

Analysis

Axsome Therapeutics (AXSM) Other Accumulated Expenses (2015 - 2026) Analysis & Trends

At the end of FY2025, Axsome Therapeutics' Other Accumulated Expenses was $150.25 million, up 103.2% from FY2024.

  • Other Accumulated Expenses has increased in each of the last three years, with a five-year compound annual growth rate of 228.3% (FY2020 to FY2025).
  • Going back by year, Other Accumulated Expenses was $73.95 million in FY2024 (+58.3%), $46.71 million in FY2023 (+76.0%), $26.55 million in FY2022 and $385,347 in FY2021 (-2.2%).
  • The Q2 2026 figure represents the highest quarterly Other Accumulated Expenses in data going back to Q4 2015.
  • Year-over-year, Other Accumulated Expenses has increased for 13 consecutive quarters, with growth averaging 82.2% over the last eight quarters.
  • The fastest year-over-year change in Other Accumulated Expenses over five years came in Q2 2023 (growth of 648.2%), and the weakest in Q3 2021 (a decline of 63.0%).
  • Business Quant data shows AXSM's Other Accumulated Expenses at $170.24 million (Q1 2026), $150.25 million (Q4 2025) and $139.47 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Axsome Therapeutics 9.37 Bn 8.10 Bn 204.81 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 204.63 Mn
Mar 31, 2026 170.24 Mn
Dec 31, 2025 150.25 Mn
Sep 30, 2025 139.47 Mn
Jun 30, 2025 118.17 Mn
Mar 31, 2025 95.77 Mn
Dec 31, 2024 73.95 Mn
Sep 30, 2024 68.77 Mn
Jun 30, 2024 63.53 Mn
Mar 31, 2024 49.34 Mn
Dec 31, 2023 46.71 Mn
Sep 30, 2023 42.40 Mn
Jun 30, 2023 36.03 Mn
Mar 31, 2023 30.43 Mn
Dec 31, 2022 26.55 Mn
Sep 30, 2022 14.46 Mn
Jun 30, 2022 4.82 Mn
Mar 31, 2022 390,556.00
Dec 31, 2021 385,347.00
Sep 30, 2021 381,250.00
API Access

Axsome Therapeutics Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=AXSM&period=max&api_key=YOUR_API_KEY